New research reveals that patients who discontinue popular GLP-1 drugs like semaglutide or tirzepatide can put back on reduced body mass far faster than those who halt traditional lifestyle plans.
Findings released in a leading health publication shows that while overweight individuals frequently drop about a fifth of their total mass while using the jabs, the mass comes back at an average rate of 0.8 kg per month after stopping.
"Users purchasing these drugs should be cognizant of the potential of fast weight regain when the therapy ends," stated expert Dr. Susan Jebb.
That rate of regain suggests a reversion to original weight within about one and a half years.
Analyzing Treatments
The analysis, which looked at 37 of studies involving over 9,000 of patients, compared the outcomes of the injectable medications with older methods.
The team note that people who shed pounds through diet and exercise usually have a less rapid weight regain—perhaps 100 grams monthly—once they finish.
The Reason for the Quick Regain
Experts suggest the way of the injections is key to understanding the accelerated regain.
These medications mimic a natural hormone called glucagon-like peptide-1, which controls hunger.
"Sustained high doses of the hormone concentrations far above than normal could lead to the body to generate a reduced amount of its own natural GLP-1, and may also lessen responsiveness to its effects," noted Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this GLP-1 'fix' means appetite is unsuppressed, making binge eating much more probable."
An Ongoing Issue?
Medical guidelines advise the injections for people with weight-linked medical conditions, alongside prescribed diet and exercise modifications.
Many experts say that, given the high risk of relapse, the treatment might need to be life-long.
This view is supported by drug manufacturers, who state that the results "underscore the chronic character of excess weight," comparing it to managing conditions like hypertension.
Patient Accounts
Users who have come off the medication explain a sudden return of appetite.
"It was like something flipping and you become ravenous," described one woman.
This challenge is exacerbated if patients have not developed sustainable dietary or behavioural modifications during therapy.
Growing Interest
Survey data show that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with desire being substantial.
- Use is greater among women than men.
- The middle-aged age group shows the greatest usage rates.
- Many access the medications through private healthcare rather than public health services.
In conclusion, clinicians stress that while these medications are powerful agents for weight loss, they are not a magic solution and long-term success relies on combined behavioural support.
